Keyphrases
β-cell Function
100%
Coronary Artery Disease
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Liraglutide
100%
Insulin Secretion
100%
Mixed Meal
100%
Glucagon
42%
Placebo
42%
Insulin Resistance
42%
Postprandial Glucose
28%
Newly Diagnosed
28%
Insulinotropic Effects
28%
Metformin
28%
Postprandial Insulin
14%
Controlled Crosses
14%
Glucagon-like
14%
Whole-body
14%
Insulin Clearance
14%
Trial Registration
14%
Receptor Agonist
14%
Meal Tolerance Test
14%
Patients with Coronary Artery Disease
14%
Hyperinsulinemia
14%
Glucose Concentration
14%
A1 Receptor
14%
α-cell Function
14%
Prandial
14%
Cardiovascular Disease
14%
Physiologic
14%
Placebo-controlled
14%
Treatment Duration
14%
C-peptide
14%
Insulin Concentration
14%
Insulin
14%
Oral Glucose Tolerance Test
14%
Washout Period
14%
Pancreatic Islet Cells
14%
Disposition Index
14%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Coronary Artery Disease
100%
Liraglutide
100%
Cell Function
100%
Insulin Release
100%
Beta Cell
100%
Placebo
57%
Glucagon
42%
Type 2 Diabetes
42%
Insulin Resistance
28%
Glycon
28%
Cardiovascular Disease
14%
C-Peptide
14%
Test Meal
14%
Glucose Tolerance
14%
Glucagon-Like Peptide-1 Agonist
14%
Insulin Clearance
14%
Hyperinsulinemia
14%
Immunology and Microbiology
Insulin Release
100%
Insulin
100%
Coronary Artery
100%
Cell Function
100%
Glucagon
75%
Insulin Resistance
50%
Insulin Clearance
25%
Peptides
25%
Glucagon-Like Peptide-1
25%
Agonist
25%
Agricultural and Biological Sciences
Insulin Secretion
100%
Epicardial Coronary Arteries
100%
Liraglutide
100%
Beta Cell
100%
Placebo
57%
Glucagon
42%
Insulin Resistance
28%
Cardiovascular System
14%
Alpha Cell
14%
Agonist
14%
Glucose Tolerance
14%
C-Peptide
14%
Glucagon-Like Peptide 1 Receptor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Liraglutide
100%
Coronary Artery Disease
100%
Non Insulin Dependent Diabetes Mellitus
100%
Placebo
57%
Glucagon
42%
Metformin
28%
Insulin Resistance
28%
Cardiovascular Disease
14%
Glucagon Like Peptide 1 Receptor Agonist
14%
C Peptide
14%
Hyperinsulinemia
14%